1-53214202-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_017887.3(CZIB):c.*457C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00936 in 165,186 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0094 ( 10 hom., cov: 33)
Exomes 𝑓: 0.0086 ( 1 hom. )
Consequence
CZIB
NM_017887.3 3_prime_UTR
NM_017887.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.431
Genes affected
CZIB (HGNC:26059): (CXXC motif containing zinc binding protein) Enables zinc ion binding activity. [provided by Alliance of Genome Resources, Apr 2022]
CPT2 (HGNC:2330): (carnitine palmitoyltransferase 2) The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-53214202-G-T is Benign according to our data. Variant chr1-53214202-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 368875.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00942 (1435/152290) while in subpopulation SAS AF = 0.0363 (175/4826). AF 95% confidence interval is 0.0319. There are 10 homozygotes in GnomAd4. There are 731 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CZIB | NM_017887.3 | c.*457C>A | 3_prime_UTR_variant | Exon 8 of 8 | ENST00000294360.5 | NP_060357.1 | ||
CPT2 | NM_000098.3 | c.*607G>T | downstream_gene_variant | ENST00000371486.4 | NP_000089.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00944 AC: 1436AN: 152172Hom.: 10 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1436
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00861 AC: 111AN: 12896Hom.: 1 Cov.: 0 AF XY: 0.00953 AC XY: 64AN XY: 6718 show subpopulations
GnomAD4 exome
AF:
AC:
111
AN:
12896
Hom.:
Cov.:
0
AF XY:
AC XY:
64
AN XY:
6718
Gnomad4 AFR exome
AF:
AC:
0
AN:
200
Gnomad4 AMR exome
AF:
AC:
4
AN:
2110
Gnomad4 ASJ exome
AF:
AC:
3
AN:
226
Gnomad4 EAS exome
AF:
AC:
3
AN:
528
Gnomad4 SAS exome
AF:
AC:
29
AN:
1188
Gnomad4 FIN exome
AF:
AC:
1
AN:
254
Gnomad4 NFE exome
AF:
AC:
68
AN:
7754
Gnomad4 Remaining exome
AF:
AC:
3
AN:
622
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00942 AC: 1435AN: 152290Hom.: 10 Cov.: 33 AF XY: 0.00982 AC XY: 731AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
1435
AN:
152290
Hom.:
Cov.:
33
AF XY:
AC XY:
731
AN XY:
74458
Gnomad4 AFR
AF:
AC:
0.00242964
AN:
0.00242964
Gnomad4 AMR
AF:
AC:
0.00751634
AN:
0.00751634
Gnomad4 ASJ
AF:
AC:
0.00605187
AN:
0.00605187
Gnomad4 EAS
AF:
AC:
0.00945581
AN:
0.00945581
Gnomad4 SAS
AF:
AC:
0.0362619
AN:
0.0362619
Gnomad4 FIN
AF:
AC:
0.0190351
AN:
0.0190351
Gnomad4 NFE
AF:
AC:
0.0110716
AN:
0.0110716
Gnomad4 OTH
AF:
AC:
0.00757576
AN:
0.00757576
Heterozygous variant carriers
0
77
154
232
309
386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
113
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Carnitine palmitoyltransferase II deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at